fluchloralin has been researched along with insulin glargine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, T; Lee, KO; Li, FF; Li, HQ; Liu, BL; Lu, CF; Ma, JH; Su, XF; Sun, R; Wang, J; Xu, XH; Ye, L; Yin, GP | 1 |
| Ding, B; Jing, T; Li, H; Ma, J; Su, X; Wang, H; Zhai, X; Zhou, Y | 1 |
| Andersen, G; Chen, W; Gan, Z; Hao, C; He, A; Heise, T; Li, L; Lu, J; Plum-Mörschel, L; Xie, T; Zijlstra, E | 1 |
2 trial(s) available for fluchloralin and insulin glargine
| Article | Year |
|---|---|
Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.
Topics: Aged; Aniline Compounds; Diabetes Mellitus, Type 2; Female; Glycemic Control; Humans; Hypoglycemic Agents; Insulin Glargine; Male; Middle Aged; Prospective Studies | 2021 |
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU- und US-sourced reference insulins.
Topics: Biosimilar Pharmaceuticals; Blood Glucose; Cross-Over Studies; Double-Blind Method; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Glargine; Insulin Lispro; Insulin, Regular, Human; Male; Therapeutic Equivalency; United States | 2023 |
1 other study(ies) available for fluchloralin and insulin glargine
| Article | Year |
|---|---|
A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type 2 diabetes using continuous glucose monitoring system.
Topics: Adolescent; Adult; Aniline Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Glargine; Male; Middle Aged; Monitoring, Physiologic; Treatment Outcome; Young Adult | 2018 |